Impact of duration of immunotherapy on clinical outcomes in advanced Merkel cell carcinoma patients responding to first-line immunotherapy Tachiki, L. M., Zawacki, L., Hippe, D. S., Moshiri, Y., Alexander, N., Akaike, T., Doolittle-Amieva, C., Pulliam, T., Zaba, L. C., Bhatia, S., Nghiem, P. ELSEVIER SCIENCE INC. 2022: 2840

View details for Web of Science ID 000888821100029